Saki Fukuda

Researcher

UAMS

Also affiliated: University of Applied Management Studies (2024); Tottori University (2020–2025)

Unknown Researcher

4 h-index 9 pubs 90 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Saki Fukuda's research focuses on the pharmacological effects of opioids and related compounds, often utilizing animal models to investigate mechanisms of action and potential therapeutic interventions. Recent work includes the development of automated methods for quantifying opioid withdrawal symptoms in neonatal rat pups and the pharmacological characterization of fentanyl analogs. Fukuda has also investigated the antidepressant effects of medium-chain triglycerides and the use of deuterated buprenorphine to mitigate fentanyl's impact in pregnant rats. This research contributes to understanding substance abuse, pain management, and maternal health. Fukuda has published nine papers with 89 citations and an h-index of 4. Key collaborators include Lisa K. Brents, William E. Fantegrossi, Kyle Urquhart, and Michael D. Berquist, all from the University of Arkansas for Medical Sciences.

Metrics

h-index: 4
Publications: 9
Citations: 90

Selected Publications

In vitro and in vivo pharmacological characterization of fentanyl analogs (2025)

Neuropharmacology 7 citations DOI OpenAlex
Automated quantification of opioid withdrawal in neonatal rat pups using Ethovision® XT software (2021)

Neurotoxicology and Teratology 15 citations DOI OpenAlex
Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity (2020)

Pharmacology Biochemistry and Behavior 17 citations DOI OpenAlex
Locomotor Effects of Substituted Amphetamines and Cathinones in Mice: Structure‐Activity Relationships (2019)

The FASEB Journal DOI OpenAlex
Pharmacological Characterization of Synthetic Cannabinoid MAM‐2201: Radioligand Binding and Abuse‐Related Effects (2018)

The FASEB Journal DOI OpenAlex